thalidomide
No data available for drug.
DRUG INTERACTION
No drug interaction found for thalidomide and .
belimumab
may have an increased immunosuppressive effect when combined with anti-psoriasis agents
alfentanil
CNS depressants increase the CNS depressing effect of
thalidomide
fentanyl
CNS depressants increase the CNS depressing effect of
thalidomide
oxymorphone
CNS depressants increase the CNS depressing effect of
thalidomide
clozapine
CNS depressants increase the CNS depressing effect of
thalidomide
ketamine
CNS depressants increase the CNS depressing effect of
thalidomide
propofol
CNS depressants increase the CNS depressing effect of
thalidomide
butabarbital
CNS depressants increase the CNS depressing effect of
thalidomide
pimozide
CNS depressants increase the CNS depressing effect of
thalidomide
midazolam
may increase the CNS depressant effect
codeine
CNS depressants increase the CNS depressing effect of thalidomide
lorazepam
CNS depressants increase the CNS depressing effect of thalidomide
reserpine
CNS depressants increase the CNS depressing effect of thalidomide
diazepam
CNS depressants increase the effect of CNS depression of thalidomide
methadone
CNS depressants increase the effect of CNS depression of thalidomide
secobarbital
CNS depressants increase the effect of CNS depression of thalidomide
estazolam
may have an increased CNS depressive effect when combined with thalidomide
oxazepam
may have an increased CNS depressive effect when combined with thalidomide
tiagabine
may have an increased CNS depressive effect when combined with thalidomide
isoflurane
CNS depressants increase the efficacy of thalidomide
promazine
CNS depressants increase the efficacy of thalidomide
sufentanil
It may increase the CNS depressant effect when combined with CNS Depressants
etoposide
when both drugs are combined, there may be an increased risk or severity of adverse effects
vincristine
when both drugs are combined, there may be an increased risk or severity of peripheral neuropathy
paclitaxel
when both drugs are combined, there may be an increased risk or severity of peripheral neuropathy
carmustine
when both the drugs are combined, the risk or severity of adverse effects decreases
topotecan
when both drugs are combined, there may be an increased risk or severity of adverse effects
lomustiine
when both drugs are combined, there may be an increased risk of dangerous blood clots
cetuximab
when both drugs are combined, there may be an increased risk of dangerous blood clots
nivolumab
taken in combination; with thalidomide and nivolumab for treating multiple myeloma may result in serious risk and life-threatening effects
avelumab
when both drugs are combined, there may be an increased risk of severe and life-threatening side effects as well as death
alprazolam
CNS depressants increase the effect of thalidomide
lorazepam
CNS depressants increase the effect of thalidomide
maprotiline
CNS depressants increase the CNS suppression effect of thalidomide
imipramine
CNS depressants increase the CNS suppression effect of thalidomide
desipramine
CNS depressants increase the CNS suppression effect of thalidomide
doxepin
CNS depressants increase the CNS suppression effect of thalidomide
selegiline
CNS depressants increase the CNS suppression effect of thalidomide
trimipramine
CNS depressants increase the CNS suppression effect of thalidomide
topiramate
CNS depressants increase the CNS suppression effect of thalidomide
perampanel
CNS depressants increase the CNS suppression effect of thalidomide
abatacept
tumor necrosis factor (TNF) blocking agent may enhance the immunosuppressive effect of abatacept
abatacept
may increase the immunosuppressive effect of abatacept
certolizumab
may increase the immunosuppressive effect of certolizumab pegol
paregoric
may increase the CNS depressant effect
tapentadol
may increase the CNS depressant effects of CNS depressants
eszopiclone
may increase the CNS depressant effect of CNS depressants
carisoprodol
may increase the CNS depressant effect of CNS depressants
meprobamate
may increase the CNS depressant effect of CNS depressants
methohexital
may increase the CNS depressant effect of CNS depressants
tizanidine
may increase the CNS depressant effect of CNS depressants
aripiprazole
may increase the CNS depressant effect of CNS Depressants
suvorexant
may increase the CNS depressant effect of CNS Depressants
chlorzoxazone
may increase the CNS depressant effect of CNS Depressants
anifrolumab
may have an increased immunosuppressive effect when combined with anifrolumab
infliximab
may have an increased immunosuppressive effect when combined with anti-psoriasis agents
phenobarbital
CNS Depressants may enhance the CNS depressant effect of thalidomide
eszopiclone
CNS Depressants may enhance the CNS depressant effect of thalidomide
oxycodone
CNS Depressants may enhance the CNS depressant effect of thalidomide
triazolam
CNS Depressants may enhance the CNS depressant effect of thalidomide
ibandronate
they increase the toxicity of bisphosphonate derivatives
peginesatide
may have an increased thrombogenic effect when combined with thalidomide
ethinyl estradiol
thalidomide: they may increase the thrombogenic effect of hormonal contraceptives
ethinylestradiol
thalidomide: they may increase the thrombogenic effect of hormonal contraceptives
ethynodiol diacetate
thalidomide: they may increase the thrombogenic effect of hormonal contraceptives
etonogestrel
thalidomide: they may increase the thrombogenic effect of hormonal contraceptives
medroxyprogesterone
The thrombogenic action of thalidomide may be increased by hormonal contraceptives
megestrol
The thrombogenic action of thalidomide may be increased by hormonal contraceptives
mefenamic acid
The thrombogenic action of thalidomide may be increased by hormonal contraceptives
nomegestrol acetate
The thrombogenic action of thalidomide may be increased by hormonal contraceptives
dienogest
hormonal contraceptives increase the effect of thrombogenesis of thalidomide
zoledronic acid
angiogenesis Inhibitors may enhance the adverse/toxic effect of bisphosphonate derivatives
alendronic acid
angiogenesis Inhibitors may enhance the adverse/toxic effect of bisphosphonate derivatives
ibandronate
angiogenesis Inhibitors may enhance the adverse/toxic effect of bisphosphonate derivatives
pamidronic acid
angiogenesis Inhibitors may enhance the adverse/toxic effect of bisphosphonate derivatives
anakinra
tumor necrosis factor (TNF) blocking agent may enhance the immunosuppressive effect of anakinra
darbepoetin alfa
may increase the thrombogenic effect of Erythropoiesis-Stimulating Agents
flibanserin
may increase the CNS depressant effect of CNS depressants
desflurane
may increase the CNS depressant effect of CNS depressants
thalidomide
No data available for drug.
DRUG INTERACTION
thalidomide
&
No Drug Intearction Found. for thalidomide and .
belimumab
may have an increased immunosuppressive effect when combined with anti-psoriasis agents
alfentanil
CNS depressants increase the CNS depressing effect of
thalidomide
fentanyl
CNS depressants increase the CNS depressing effect of
thalidomide
oxymorphone
CNS depressants increase the CNS depressing effect of
thalidomide
clozapine
CNS depressants increase the CNS depressing effect of
thalidomide
ketamine
CNS depressants increase the CNS depressing effect of
thalidomide
propofol
CNS depressants increase the CNS depressing effect of
thalidomide
butabarbital
CNS depressants increase the CNS depressing effect of
thalidomide
pimozide
CNS depressants increase the CNS depressing effect of
thalidomide
midazolam
may increase the CNS depressant effect
codeine
CNS depressants increase the CNS depressing effect of thalidomide
lorazepam
CNS depressants increase the CNS depressing effect of thalidomide
reserpine
CNS depressants increase the CNS depressing effect of thalidomide
diazepam
CNS depressants increase the effect of CNS depression of thalidomide
methadone
CNS depressants increase the effect of CNS depression of thalidomide
secobarbital
CNS depressants increase the effect of CNS depression of thalidomide
estazolam
may have an increased CNS depressive effect when combined with thalidomide
oxazepam
may have an increased CNS depressive effect when combined with thalidomide
tiagabine
may have an increased CNS depressive effect when combined with thalidomide
isoflurane
CNS depressants increase the efficacy of thalidomide
promazine
CNS depressants increase the efficacy of thalidomide
sufentanil
It may increase the CNS depressant effect when combined with CNS Depressants
etoposide
when both drugs are combined, there may be an increased risk or severity of adverse effects
vincristine
when both drugs are combined, there may be an increased risk or severity of peripheral neuropathy
paclitaxel
when both drugs are combined, there may be an increased risk or severity of peripheral neuropathy
carmustine
when both the drugs are combined, the risk or severity of adverse effects decreases
topotecan
when both drugs are combined, there may be an increased risk or severity of adverse effects
lomustiine
when both drugs are combined, there may be an increased risk of dangerous blood clots
cetuximab
when both drugs are combined, there may be an increased risk of dangerous blood clots
nivolumab
taken in combination; with thalidomide and nivolumab for treating multiple myeloma may result in serious risk and life-threatening effects
avelumab
when both drugs are combined, there may be an increased risk of severe and life-threatening side effects as well as death
alprazolam
CNS depressants increase the effect of thalidomide
lorazepam
CNS depressants increase the effect of thalidomide
maprotiline
CNS depressants increase the CNS suppression effect of thalidomide
imipramine
CNS depressants increase the CNS suppression effect of thalidomide
desipramine
CNS depressants increase the CNS suppression effect of thalidomide
doxepin
CNS depressants increase the CNS suppression effect of thalidomide
selegiline
CNS depressants increase the CNS suppression effect of thalidomide
trimipramine
CNS depressants increase the CNS suppression effect of thalidomide
topiramate
CNS depressants increase the CNS suppression effect of thalidomide
perampanel
CNS depressants increase the CNS suppression effect of thalidomide
abatacept
tumor necrosis factor (TNF) blocking agent may enhance the immunosuppressive effect of abatacept
abatacept
may increase the immunosuppressive effect of abatacept
certolizumab
may increase the immunosuppressive effect of certolizumab pegol
paregoric
may increase the CNS depressant effect
tapentadol
may increase the CNS depressant effects of CNS depressants
eszopiclone
may increase the CNS depressant effect of CNS depressants
carisoprodol
may increase the CNS depressant effect of CNS depressants
meprobamate
may increase the CNS depressant effect of CNS depressants
methohexital
may increase the CNS depressant effect of CNS depressants
tizanidine
may increase the CNS depressant effect of CNS depressants
aripiprazole
may increase the CNS depressant effect of CNS Depressants
suvorexant
may increase the CNS depressant effect of CNS Depressants
chlorzoxazone
may increase the CNS depressant effect of CNS Depressants
anifrolumab
may have an increased immunosuppressive effect when combined with anifrolumab
infliximab
may have an increased immunosuppressive effect when combined with anti-psoriasis agents
phenobarbital
CNS Depressants may enhance the CNS depressant effect of thalidomide
eszopiclone
CNS Depressants may enhance the CNS depressant effect of thalidomide
oxycodone
CNS Depressants may enhance the CNS depressant effect of thalidomide
triazolam
CNS Depressants may enhance the CNS depressant effect of thalidomide
ibandronate
they increase the toxicity of bisphosphonate derivatives
peginesatide
may have an increased thrombogenic effect when combined with thalidomide
ethinyl estradiol
thalidomide: they may increase the thrombogenic effect of hormonal contraceptives
ethinylestradiol
thalidomide: they may increase the thrombogenic effect of hormonal contraceptives
ethynodiol diacetate
thalidomide: they may increase the thrombogenic effect of hormonal contraceptives
etonogestrel
thalidomide: they may increase the thrombogenic effect of hormonal contraceptives
medroxyprogesterone
The thrombogenic action of thalidomide may be increased by hormonal contraceptives
megestrol
The thrombogenic action of thalidomide may be increased by hormonal contraceptives
mefenamic acid
The thrombogenic action of thalidomide may be increased by hormonal contraceptives
nomegestrol acetate
The thrombogenic action of thalidomide may be increased by hormonal contraceptives
dienogest
hormonal contraceptives increase the effect of thrombogenesis of thalidomide
zoledronic acid
angiogenesis Inhibitors may enhance the adverse/toxic effect of bisphosphonate derivatives
alendronic acid
angiogenesis Inhibitors may enhance the adverse/toxic effect of bisphosphonate derivatives
ibandronate
angiogenesis Inhibitors may enhance the adverse/toxic effect of bisphosphonate derivatives
pamidronic acid
angiogenesis Inhibitors may enhance the adverse/toxic effect of bisphosphonate derivatives
anakinra
tumor necrosis factor (TNF) blocking agent may enhance the immunosuppressive effect of anakinra
darbepoetin alfa
may increase the thrombogenic effect of Erythropoiesis-Stimulating Agents
flibanserin
may increase the CNS depressant effect of CNS depressants
desflurane
may increase the CNS depressant effect of CNS depressants
medtigo
thalidomide
Action and Spectrum
Drug Interaction
Adverse Reaction
Black Box Warning
Contraindication / Caution
Pregnancy / Lactation
Pharmacology
Adminstartion
Patient Information Leaflet